Cargando…

Safety Profile and Tolerability of Topical Phosphodiesterase 4 Inhibitors for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis

OBJECTIVE: Evaluate the safety profile and tolerability of topical phosphodiesterase 4 (PDE4) inhibitors versus vehicle as treatment for atopic dermatitis in published studies. METHODS: A search was performed in Medline/PubMed, Web of Science, and Cochrane Library databases on September 27, 2021, by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martín-Santiago, Ana, Puig, Susana, Arumi, Daniel, Rebollo Laserna, Francisco Jose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278032/ https://www.ncbi.nlm.nih.gov/pubmed/35846836 http://dx.doi.org/10.1016/j.curtheres.2022.100679

Ejemplares similares

Topical Janus kinase inhibitors in atopic dermatitis: a safety network meta-analysis
por: Alves, Carlos, et al.
Publicado: (2023)

Tolerability of Topical Treatments for Atopic Dermatitis
por: Draelos, Zoe D., et al.
Publicado: (2019)

Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis
por: Iznardo, Helena, et al.
Publicado: (2023)

Tolerability of and Adherence to Topical Treatments in Atopic Dermatitis: A Narrative Review
por: Tier, Heather L., et al.
Publicado: (2021)

Efficacy and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis: meta-analysis of randomized clinical trials
por: £abędź, Natalia, et al.
Publicado: (2019)

Topical Calcineurin Inhibitors for Atopic Dermatitis: Review and Treatment Recommendations
por: Carr, Warner W.
Publicado: (2013)

Quantifying Physician Preferences for Systemic Atopic Dermatitis Treatments Using a Discrete-Choice Experiment
por: Carrascosa Carrillo, José Manuel, et al.
Publicado: (2022)

CSACI position statement: safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults
por: Segal, Audrey O, et al.
Publicado: (2013)

Topical tacrolimus as treatment of atopic dermatitis
por: Furue, Masutaka, et al.
Publicado: (2009)

Topical steroid addiction in atopic dermatitis
por: Fukaya, Mototsugu, et al.
Publicado: (2014)

Topical Therapy in Atopic Dermatitis in Children
por: Sathishkumar, Dharshini, et al.
Publicado: (2016)

What’s New in Topicals for Atopic Dermatitis?
por: Kleinman, Elana, et al.
Publicado: (2022)

Patient Journey in Atopic Dermatitis: The Real-World Scenario
por: Carrascosa, Jose Manuel, et al.
Publicado: (2021)

Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis
por: Siegfried, Elaine C., et al.
Publicado: (2016)

Process utilities for topical treatment in atopic dermatitis
por: Retzler, Jenny, et al.
Publicado: (2019)

The long‐term safety of topical corticosteroids in atopic dermatitis: A systematic review
por: Harvey, Jane, et al.
Publicado: (2023)

Efficacy and safety of topical OPA‐15406, a new phosphodiesterase 4 inhibitor, in Japanese patients with atopic dermatitis for 8 weeks: A phase 2, randomized, double‐blind, placebo‐controlled study
por: Saeki, Hidehisa, et al.
Publicado: (2019)

Reflectance Confocal Microscopy in Monitoring Atopic Dermatitis Treated with Topical Calcineurin Inhibitors
por: Bratu, Dalia, et al.
Publicado: (2023)

Long‐term safety and efficacy of delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with atopic dermatitis
por: Nakagawa, Hidemi, et al.
Publicado: (2019)

Topical steroid therapy in atopic dermatitis in theory and practice
por: Jeziorkowska, Renata, et al.
Publicado: (2015)

Staphylococcus aureus resistance to topical antimicrobials in atopic dermatitis
por: Bessa, Giancarlo Rezende, et al.
Publicado: (2016)

Atopic dermatitis: a review of topical nonsteroid therapy
por: Papier, Ariana, et al.
Publicado: (2018)

Topical Tacrolimus for the Treatment of Atopic Dermatitis with Truncal Lesion
por: Ko, Hyun Chang, et al.
Publicado: (2018)

Topical treatment with SPHINGOLIPIDS and GLYCOSAMINOGLYCANS for canine atopic dermatitis
por: Marsella, Rosanna, et al.
Publicado: (2020)

Novel Therapeutic Strategies in the Topical Treatment of Atopic Dermatitis
por: Pinto, Lorenzo Maria, et al.
Publicado: (2022)

From the Cochrane Library: Topical Tacrolimus for Atopic Dermatitis
por: Hamp, Austin, et al.
Publicado: (2021)

Phosphodiesterase-5 inhibitors in management of pulmonary hypertension: safety, tolerability, and efficacy
por: Buckley, Mitchell S, et al.
Publicado: (2010)

Phosphodiesterase 4D, miR-203 and selected cytokines in the peripheral blood are associated with canine atopic dermatitis
por: Koury, Jeffrey, et al.
Publicado: (2019)

Nomenclature and clinical phenotypes of atopic dermatitis
por: Girolomoni, Giampiero, et al.
Publicado: (2021)

Effectiveness and Safety of Upadacitinib in Combination with Topical Corticosteroids in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
por: Hagino, Teppei, et al.
Publicado: (2023)

Pharmacokinetics, Safety, and Tolerability of Tezepelumab (AMG 157) in Healthy and Atopic Dermatitis Adult Subjects
por: Parnes, Jane R., et al.
Publicado: (2019)

New Biologics for the Treatment of Atopic Dermatitis: Analysis of Efficacy, Safety, and Paradoxical Atopic Dermatitis Acceleration
por: Qi, Hong-jiao, et al.
Publicado: (2021)

Topical and Oral Therapies for Childhood Atopic Dermatitis and Plaque Psoriasis
por: Frantz, Travis, et al.
Publicado: (2019)

Addressing topical corticosteroid phobia in atopic dermatitis: The role of the pharmacist
por: Ladda, Matthew, et al.
Publicado: (2021)

Efficacy and tolerance of tacrolimus and pimecrolimus for atopic dermatitis: a meta-analysis
por: Yin, Zhiqiang, et al.
Publicado: (2011)

The efficacy and safety of IL-13 inhibitors in atopic dermatitis: A systematic review and meta-analysis
por: Zhang, Yan, et al.
Publicado: (2022)

Potential application of PS-OCT in the safety assessment of non-steroidal topical creams for atopic dermatitis treatment
por: Duan, M. Q., et al.
Publicado: (2023)

Baricitinib Lipid-Based Nanosystems as a Topical Alternative for Atopic Dermatitis Treatment
por: Garrós, Núria, et al.
Publicado: (2023)

Management of atopic dermatitis: safety and efficacy of phototherapy
por: Patrizi, Annalisa, et al.
Publicado: (2015)

Janus kinase inhibitors for the therapy of atopic dermatitis
por: Traidl, Stephan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2ba2j5hn1lfhtn76gntlk4ehjc